RETINOIC ACID SYNDROME

This adverse event was reported 172 times

These drugs are most commonly taken by patients reporting RETINOIC ACID SYNDROME:

# Drug Count
0 TRETINOIN 72
1 CYTARABINE 39
2 MITOXANTRONE 15
3 MITOXANTRONE HYDROCHLORIDE 15
4 DEXAMETHASONE 14
5 DEXAMETHASONE 1.5 MG 14
6 METHOTREXATE 10
7 METHOTREXATE SODIUM 10
8 ARSENIC TRIOXIDE 8
9 ALLOPURINOL 7
See all common drugs associated with RETINOIC ACID SYNDROME

RETINOIC ACID SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRETINOIN 72 0.0088
1 ARSENIC TRIOXIDE 8 0.0035
2 DEXRAZOXANE FOR INJECTION 3 0.0032
3 MITOXANTRONE HYDROCHLORIDE 15 0.0024
4 IDARUBICIN HYDROCHLORIDE 2 0.0017
5 ACYCLOVIR SODIUM 2 0.0016
6 BEXAROTENE 2 0.0015
7 TOLNAFTATE 1 0.0008
8 CYTARABINE 39 0.0006
9 CASPOFUNGIN ACETATE 1 0.0006
See all drugs enriched for association with RETINOIC ACID SYNDROME

RETINOIC ACID SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antifibrinolytic Agent [EPC] 3 0.0003
1 Retinoid [EPC] 74 0.0003
2 CD33-directed Immunoconjugate [EPC] 1 0.0003
3 Photoenhancer [EPC] 1 0.0003
4 Lipid-based Polyene Antifungal [EPC] 3 0.0002
5 Penem Antibacterial [EPC] 5 0.0001
6 Nucleoside Metabolic Inhibitor [EPC] 40 0.0001
7 Echinocandin Antifungal [EPC] 1 0.0001
8 Polyene Antifungal [EPC] 4 0.0001
9 Azole Antifungal [EPC] 15 0.0001
See all drug classes enriched for association with RETINOIC ACID SYNDROME